[1] CHEN J,LIU J,ZHANG Y,et al. China Intracranial Aneurysm Project (CIAP):protocol for a registry study on a multidimensional prediction model for rupture risk of unruptured intracranial aneurysms[J]. J Transl Med,2018,16(1):263.
[2] MOCCO J,BROWN RD J R,TORNER J C,et al.International Study of Unruptured Intracranial Aneurysms Investigators. Aneurysm Morphology and Prediction of Rupture:An International Study of Unruptured Intracranial Aneurysms Analysis[J]. Neurosurgery,2018,82(4):491-496.
[3] UCAS Japan Investigators,MORITA A,KIRINO T,et al.The natural course of unruptured cerebral aneurysms in a Japanese cohort[J].N Engl J Med,2012,366(26):2474-2482.
[4] 黄清海,杨鹏飞.颅内动脉瘤血管内介入治疗中国专家共识(2013)[J].中国脑血管病杂志,2013,10(11):606-616.
[5] TAYLOR B E S,APPELBOOM G,ZILINYI R,et al.Role of the complement cascade in cerebral aneurysm formation,growth,and rupture[J].Neuroimmunol Neuroinflamm,2015,2(2):93-101.
[6] MACDONALD R L,SCHWEIZER T A. Spontaneous subarachnoid haemorrhage[J].Lancet,2017,389:655.
[7] DIETZ S M,KUIPERS I M,TACKE C E A,et al. Giant aneurysms:a gender-specific complication of Kawasaki disease?[J].J Cardiol,2017,70(4):359-365.
[8] KAGAMI S,KANARI H,SUTO A,et al.HMG-Co A reductase inhibitor simvastatin inhibits pro-inflammatory cytokine production from murine mast cells[J].Int Arch Allergy Immunol,2008,146(suppl 1):61.
[9] FEIGIN V L,RINKEL G J,LAWES C M,et al.Risk factors for subarachnoid hemorrhage:an updated systematic review of epidemiological studies[J]. Stroke,2005,36(12):2773-2780.
[10] VLAK M H,RINKEL G J,GREEBE P,et al. Independent risk factors for intracranial aneurysms and their joint effect:a case-control study[J]. Stroke,2013,44(4):984-987. |